irasia.com - Investor Relations Asia Pacific
HOME

Living Cell Technologies Limited

Press Releases


Please download the latest "Acrobat Reader" to view the PDF.

  • 2022-December-5
  • Appointment of Mr Madhukar Bhalla as Company Secretary (in PDF)
  • 2022-November-24
  • Cessation of OptiCellAI Agreement (in PDF)
  • 2022-November-4
  • Cancellation of Online Attendance Option for 2022 AGM (in PDF)
  • 2022-November-1
  • 2022 AGM Update - Withdrawal of Resolutions (in PDF)
  • 2022-October-31
  • Board Changes (in PDF)
  • 2022-October-28
  • Appendix 4C Quarterly Activities Report for the Quarter Ended 30 September 2022 (in PDF)
  • 2022-October-27
  • Online Attendance Option for 2022 Annual General Meeting (in PDF)
  • 2022-October-12
  • Chairman's Letter to Shareholders (in PDF)
  • 2022-September-30
  • Notice of Annual General Meeting (in PDF)
  • 2022-September-27
  • NEW 2022 Annual General Meeting Date (in PDF)
  • 2022-September-19
  • 2022 Annual General Meeting Date (in PDF)
  • 2022-September-16
  • New Milestone as LCT and OptiCellAI Advance AI for NTCELL's Manufacture (in PDF)
  • 2022-August-31
  • Preliminary Final Report for the Year Ended 30 June 2022 (in PDF)
  • 2022-August-16
  • Choroid Plexus Tissue Shipped to Sydney as NTCELL Research Advances (in PDF)
  • 2022-July-29
  • Appendix 4C Quarterly Activities Report for the Quarter Ended 30 June 2022 (in PDF)
  • 2022-June-21
  • LCT Presenting at Gold Coast Investment Showcase (in PDF)
  • 2022-June-3
  • Cleansing Notice under Section 708A(5)(e) of the Corporations Act 2001 (Cth) (in PDF)
  • 2022-May-31
  • LCT Completes Strategic A$1.285M Placement in Boost for Parkinson's Disease Research (in PDF)
  • 2022-May-23
  • Artificial Intelligence to Advance NTCELL Production; Agreement Signed with Sydney-Based Start-Up OptiCellAI (in PDF)
  • 2022-April-29
  • Appendix 4C Quarterly Activities Report for the Quarter Ended 31 March 2022 (in PDF)
  • 2022-April-28
  • Cleansing Notice Under Section 708AA(2)(f) of the Corporations Act 2001 (Cth) (in PDF)
  • 2022-April-28
  • Chairman's Address Extraordinary General Meeting 28 April 2022 (in PDF)
  • 2022-March-30
  • NTCELL to Be Produced in Australia for 1st Time under UTS Research Agreement (in PDF)
  • 2022-March-25
  • General Meeting of Shareholders (in PDF)
  • 2022-March-21
  • Funding Update-LCT Advancing NTCELL with Investor Backing (in PDF)
  • 2022-March-04
  • Investor Webinar (in PDF)
  • 2022-February-28
  • LCT Interim CEO's Term Extended as NTCELL Advances (in PDF)
  • 2022-February-25
  • LCT Half Yearly Report Period Ended 31 December 2021 (in PDF)
  • 2022-January-31
  • Appendix 4C Quarterly Activities Report for the Quarter Ended 31 December 2021 (in PDF)
  • 2022-January-24
  • LCT Signs Service Agreement with NZeno, Secures Pig Cells for NTCELL® Trial (in PDF)
  • 2023
  • 2023 Press Releases
  • 2021
  • 2021 Press Releases
  • 2020
  • 2020 Press Releases
  • 2019
  • 2019 Press Releases
  • 2018
  • 2018 Press Releases
  • 2017
  • 2017 Press Releases
  • 2016
  • 2016 Press Releases
  • 2015
  • 2015 Press Releases
  • 2014
  • 2014 Press Releases
  • 2013
  • 2013 Press Releases
  • 2012
  • 2012 Press Releases
  • 2011
  • 2011 Press Releases
  • 2010
  • 2010 Press Releases
  • 2009
  • 2009 Press Releases
  • 2008
  • 2008 Press Releases
  • 2007
  • 2007 Press Releases


  • Company's Index
  • irasia.com

  • About irasia.com   |   Terms of Use   |   Privacy Policy Statement   |   Disclaimer
    © Copyright 1996-2024 irasia.com Ltd. All rights reserved.
    DISCLAIMER:
    irasia.com Ltd. makes no guarantee as to the accuracy or completeness of any information provided on this website. Under no circumstances shall irasia.com Ltd. be liable for damages resulting from the use of the information provided on this website.